WHAT ARE THE USES OF BORTEZOMIB INJECTION? Introduction: Bortezomib is an anti-cancer drug used for the treatment of patients with multiple myeloma and mantle cell lymphoma. This includes patients with multiple myeloma who have and have not been previously taken treatment. The bortezomib injection is generally prescribed along with other medications.
What is Bortezomib? Bortezomib specifically is a proteasome inhibitor. It works by inhibiting or blocking proteasomes, cellular complexes that break down proteins. The bortezomib is specifically originated for treating patients with multiple myeloma. Bortezomib also can be used for treating mantle cell lymphoma in recipients who have already been treated with a minimum of one other type of therapy. This proteasome inhibitor is being studied in the treatment of certain types of other cancer. It blocks several molecular pathways in a cell and may help cause cancerous cells to die. Along with the proteasome inhibitor, it is a type of dipeptidyl boronic acid. It can also be known as PS-341.
How to Take Bortezomib: The bortezomib 2mg/ 3.5mg drug is prescribed by a specialist experienced in the use of medications for the treatment of cancer. The bortezomib injection is administered by a healthcare professional into the vein (intravenously, or IV) or under the skin (subcutaneously, or SC). Bortezomib must not be administered into the spinal fluid (intrathecally).
Price & Storage: The bortezomib injection price in India is quite reasonable at each and every certified (ISO & WHO-GDP) pharmaceutical wholesaler or pharmacy. Prices of bortezomib usually may vary depending on the non-branded (generic) to branded (innovator) version drugs. The reconstituted bortezomib is administered within the eight hours of preparation. When reconstituted as instructed, bortezomib may be stored at temperature 25°C (77°F). The reconstituted material can be stored in the original vial or the syringe prior to the administration.
Source: http://the-indian-pharma.over-blog.com/what-are-the-uses-ofbortezomib-injection.html